https://www.selleckchem.com/products/nbqx.html
Norovirus is a substantial burden on the U.S. We compared norovirus outbreaks before and during COVID-19. There were fewer norovirus outbreaks during COVID-19 compared to a similar time period in 2019 (326 versus 638, P less then 0.001). CONCLUSION COVID-19 public health interventions may be considered to decrease the burden of norovirus. This demonstrates the ability of more restrictive interventions to decrease other outbreaks of known or emerging viruses. The SYNTAX trial was designed to evaluate whether multivessel disease patients cou
Like
Comment
Share
